All lobbying filings

MEHLMAN CONSULTING, INC.

MEHLMAN CONSULTING, INC. filed a Q2 report for ELEVANCE HEALTH, INC. on July 17, 2026, reporting $90,000 in lobbying income.

Lobbying for ELEVANCE HEALTH, INC. · Health Benefits Provider

All filings by MEHLMAN CONSULTING, INC. · Everything ELEVANCE HEALTH, INC. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 17, 2026

Income

$90,000

What the client paid this registrant for the period.

Client based in

Indiana

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 4

Health Issues

Issues related to health insurance price transparency. Issues related to prescription drug costs and delivery. Issues related to Surprise Billing.

Medicare/Medicaid

Medicare Advantage, Medicare Part D, Medicaid Managed Care. Issues related to prescription drug costs and delivery. PBM Reform issues. CY 2027 Medicare Advantage Rate Notice. S. 1105 - No UPCODE Act.

Pharmacy

Prescription Drug Pricing.

Taxation/Internal Revenue Code

Issues related to tax-preferred accounts to help lower the cost of insurance.

Bills named in this filing 1

S. 1105
No UPCODE Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.